Targeting Protein Tyrosine Phosphatases to Improve Cancer Immunotherapies

Targeting Protein Tyrosine Phosphatases to Improve Cancer Immunotherapies

Advances in immunotherapy have brought significant therapeutic benefits to many cancer patients. Nonetheless, many cancer types are refractory to current immunotherapeutic approaches, meaning that further targets are required to increase the number of patients who benefit from these technologies. Pr...

Full description

Bibliographic Details
Main Author: Robert J. Salmond
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Cells
Subjects:
protein tyrosine phosphatase (non-receptor type)
cancer immunotherapy
tumour suppressor
oncogene
T cells
cell signalling
Online Access:https://www.mdpi.com/2073-4409/13/3/231

Internet

https://www.mdpi.com/2073-4409/13/3/231

Similar Items